Combination therapies with ponatinib and asciminib in a preclinical model of chronic myeloid leukemia blast crisis with compound mutations

Nikola Curik,Adam Laznicka,Vaclava Polivkova,Jitka Krizkova,Eva Pokorna,Pavel Semerak,Pavla Suchankova,Pavel Burda,Andreas Hochhaus,Katerina Machova Polakova

DOI: https://doi.org/10.1038/s41375-024-02248-0

2024-04-14

Leukemia

Abstract:Leukemia, Published online: 13 April 2024; doi:10.1038/s41375-024-02248-0 Combination therapies with ponatinib and asciminib in a preclinical model of chronic myeloid leukemia blast crisis with compound mutations

oncology,hematology